Fig. 5From: Development and validation of a multi-modal ultrasomics model to predict response to neoadjuvant chemoradiotherapy in locally advanced rectal cancerRegion of Interest (ROI) for rectal cancer tumors. (A-F) A patient who had a good response after neoadjuvant chemoradiotherapy. (G-L) A patient who had a poor response after neoadjuvant chemoradiotherapy. A, G Raw images of tumors from B-mode ultrasound; D, J Raw images of tumors from contrast-enhanced ultrasound. B, E, H, K tracing tumors’ ROI (yellow curve represents the tracing pathway); C, F, I, L Confirming tumors’ ROI (green area)Back to article page